d-Looking Statements in this press release as
well as all financial documents filed by Hillenbrand Industries or its
subsidiaries with the SEC. Hillenbrand Industries, Inc. provides earnings
per share guidance on an adjusted basis from continuing operations because
the company's management believes that the presentation provides useful
information to investors. Among other things, it may assist investors in
evaluating the company's operations period over period -- which is also the
basis on which it generally is most reasonable to forecast results. This
measure may exclude such items as strategic developments (including
restructurings and product line changes) and significant litigation.
Special items may be highly variable, difficult to predict, and of a size
that sometimes have substantial impact on the company's reported operations
for a period. Often, prospective quantification of them is not feasible.
Management uses these measures internally for planning, forecasting and
evaluating the performance of the business, including allocating resources
and evaluating results relative to employee performance compensation
targets. Investors should consider non-GAAP measures in addition to, not as
a substitute for, or as superior to, measures of financial performance
prepared in accordance with GAAP.
As previously announced, the separation also remains subject to the
final approval of the Board of Directors, favorable market conditions,
effectiveness of the Form 10 registration statement with the SEC, and other
customary conditions. As previously disclosed, the company has already
received a favorable tax ruling from the U.S. Internal Revenue Service
(IRS).
ABOUT HILLENBRAND INDUSTRIES, INC.
Hillenbrand Industries is organized into two operating companies
serving the health care and funeral services industries.
Hill-Rom is a leading worldwide manufacturer and provider of medical
technologies and related services for the health care industry, i
'/>"/>
SOURCE Hillenbrand Industries, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine news :1.
Hillenbrand Industries Announces Fourth Quarter 2007 Dividend2.
Hillenbrand Industries Announces Second Quarter 2008 Dividend3.
Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation4.
Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 20095.
Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.6.
Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators7.
JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results8.
Verdict One Releases Directory of Board Certified Attorneys for Consumers9.
Academy releases emergency preparedness tools to enable millions more people to shelter in place10.
Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study11.
MITEM Releases Blue Iris eLaborate 8.6